The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.

NCT00315445 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
134
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Purdue Pharma LP